NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-09 · 398 (9) · 11073-11092
DOI: 10.1007/s00210-025-04030-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 21.03.2025. Verfasst von Hamza Abu Owida und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Engineering, Faculty of Engineering, Al-Ahliyya Amman University, Amman, 19328, Jordan. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Neoplasms, Biological Products, Inflammasomes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 176 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Engineering, Faculty of Engineering, Al-Ahliyya Amman University, Amman, 19328, Jordan.
- Department of Medical Laboratories Techniques, College of Health and Medical Technology, University of Al Maarif, Ramadi, Al Anbar, 31001, Iraq. ahmed.yassin@uoa.edu.iq.
- Department of Chemistry, University College of Duba, University of Tabuk, Tabuk, Saudi Arabia.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
- Chandigarh Pharmacy College, Chandigarh Group of Colleges, Jhanjeri, Mohali, 140307, Punjab, India.
- Department of Neurology, vice rektor of Bukhara State Medical Institute, Bukhara, Uzbekistan.
Zitieren
APA
Owida, H. A., Abed, A. Y., Altalbawy, F. M. A., H, M., Abbot, V., Jakhonkulovna, S. M., Mohammad, S. I., Vasudevan, A., Khalaf, R. M., & Zwamel, A. H. (2025). NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(9), 11073-11092. https://doi.org/10.1007/s00210-025-04030-0
Vancouver
Owida HA, Abed AY, Altalbawy FMA, H M, Abbot V, Jakhonkulovna SM, et al. NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(9):11073-11092. doi:10.1007/s00210-025-04030-0
BibTeX
@article{Owida2025,
author = {Owida, Hamza Abu and Abed, Ahmed Yaseen and Altalbawy, Farag M A and H, Malathi and Abbot, Vikrant and Jakhonkulovna, Sanoeva Matlyuba and Mohammad, Suleiman Ibrahim and Vasudevan, Asokan and Khalaf, Reem Mohsin and Zwamel, Ahmed Hussein},
title = {NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
volume = {398},
number = {9},
pages = {11073--11092},
doi = {10.1007/s00210-025-04030-0}
}
EUVIMED